Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Merck & Co
(NY:
MRK
)
125.89
+0.45 (+0.36%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Merck & Co
< Previous
1
2
...
26
27
28
29
30
31
32
33
34
...
69
70
Next >
Moderna's Data From Personalized Cancer Vaccine Provides Relief To Investors, Analyst Says
December 13, 2022
Via
Benzinga
Why Moderna Stock Is Skyrocketing Today
December 13, 2022
Moderna's personalized cancer vaccine program just received a big boost.
Via
The Motley Fool
2 Nasdaq Stocks Taking Big Strides Forward
December 13, 2022
As markets soar following a healthy inflation report, investors are watching these two companies closely.
Via
The Motley Fool
Moderna (MRNA) Stock Soars on Cancer Vaccine News
December 13, 2022
Moderna (MRNA) stock is rising higher on Tuesday following the release of data from a Phase 2B cancer vaccine clinical trial.
Via
InvestorPlace
Moderna-Merck Partnered Cancer Vaccine Meets Primary Efficacy Endpoint, Stock Jumps
December 13, 2022
Via
Benzinga
Why Merck's $250 Million Investment In Moderna May Have Just Paid Off
December 13, 2022
Merck opted into Moderna's cancer vaccine. Now, the companies have Phase 2 data.
Via
Investor's Business Daily
Here's How Much $100 Invested In Merck & Co 5 Years Ago Would Be Worth Today
December 08, 2022
Via
Benzinga
Mirati Wins FDA Approval For Amgen-Rivaling Cancer Drug As Wild Stock Swing Continues
December 12, 2022
FDA action on its KRAS-blocking drug could help recently downtrodden Mirati.
Via
Investor's Business Daily
3 High-Flying Stocks in 2022 That Should Keep Soaring in 2023
December 10, 2022
These stocks' tailwinds should continue blowing in the new year.
Via
The Motley Fool
Cloud Stocks: Veeva CRM Will Move To Vault Platform
December 09, 2022
Veeva will be focusing on Vault CRM for pharma and biotech, where it has the broadest portfolio.
Via
Talk Markets
Stryker, Freeport-McMoRan, Southwest Gas And This Health Care Major Feature On CNBC's 'Final Trades'
December 09, 2022
On CNBC’s "Halftime Report Final Trades," Brenda Vingiello of Sand Hill Global Advisors chose Stryker Corporation (NYSE: SYK), saying all medical procedures that
Via
Benzinga
Why Shares of Mirati Therapeutics Fell Wednesday
December 07, 2022
The company presented phase 2 data from its non-small cell lung cancer therapy.
Via
The Motley Fool
GSK's Jemperli/Chemo Combo Shows Response Rate Of 46% In Head-To-Head Lung Cancer Trial
December 07, 2022
Via
Benzinga
3 High-Yielding Stocks That Are Up 27%-Plus This Year
December 07, 2022
Is it too late to buy these soaring stocks?
Via
The Motley Fool
A Look Into Merck & Co's Debt
December 07, 2022
Over the past three months, shares of Merck & Co Inc. (NYSE:MRK) increased by 24.60%. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its...
Via
Benzinga
Why Is Gossamer Bio (GOSS) Stock Down Over 70% Today?
December 06, 2022
GOSS stock is plunging over 70%. The company's hypertension drug reportedly failed to perform better than a competing treatment.
Via
InvestorPlace
Mirati Therapeutics Crashes As The Cancer Rivalry With Amgen Heats Up
December 06, 2022
The combination with Keytruda appears safe, but effectiveness questions persist.
Via
Investor's Business Daily
Mirati Experimental Lung Cancer Drug Shows Favorable Tolerability, Promising Efficacy
December 06, 2022
Via
Benzinga
Will Black Friday Push The S&P 500 Over Its 200DMA?
December 03, 2022
U.S. stocks reversed the rally spurred by inflation data. Fed officials dispelled hopes that the central bank would moderate interest rate increases.
Via
Talk Markets
What Bear Market? This Top-Performing Dow Stock Has Thrived in 2022.
December 03, 2022
The company is having a record-smashing year.
Via
The Motley Fool
Should Investors Consider These 3 Low-Beta Stocks?
December 03, 2022
A hawkish Federal Reserve has been a thorn in the side of many stocks in 2022, causing widespread volatility. Other than energy, the market landscape has been dim.
Via
Talk Markets
Merck & Co Unusual Options Activity
December 02, 2022
Someone with a lot of money to spend has taken a bearish stance on Merck & Co (NYSE:MRK). And retail traders should know. We noticed this today when the big position showed up on publicly available...
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 29, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
December 01, 2022
During Thursday's session, 108 stocks hit new 52-week highs.
Via
Benzinga
3 Dow Stocks to Take Seriously in 2023
November 29, 2022
The top Dow stocks for 2023 are all big free cash flow generators that ought to be able to cope with whatever next year brings.
Via
InvestorPlace
Cramer Expects Dow's Outperformance To Last 'Longer' As Traders Chase 'Old-Fashioned, Profitable' Companies Amid Uncertainty
November 29, 2022
The Dow Industrials Average, a price-weighted average that tracks the performance of 30 blue-chip stocks, has outperformed the broader S&P 500 Index and the tech-weighted Nasdaq Composite
Via
Benzinga
3 Reasons Pfizer Stock Will Crush the Broader Market in 2023
November 29, 2022
Pfizer's revenue growth is far from over.
Via
The Motley Fool
Stocks Take A Hit As Wall Street Eyes China Covid Unrest
November 28, 2022
st week's mostly upbeat sentiment was forgotten on Monday as investors anxiously eyed the pushback the Chinese government is receiving for its prolonged Covid-19 restrictions.
Via
Talk Markets
10 Health Care Stocks Whale Activity In Today's Session
November 28, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Merck & Co Unusual Options Activity
November 28, 2022
A whale with a lot of money to spend has taken a noticeably bullish stance on Merck & Co. Looking at options history for Merck & Co (NYSE:MRK) we detected 16 strange trades.
Via
Benzinga
< Previous
1
2
...
26
27
28
29
30
31
32
33
34
...
69
70
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.